Season's greetings from MBS Consulting and a big thank you to for the trust our clients placed in us. May the new year bring new opportunities and successes. 🎄 ✨ ❄
Info
Drug Discovery & CMC Expertise for Biotech & Pharma
- Website
-
https://mbs-consulting.ch
Externer Link zu MBS CONSULTING
- Branche
- Unternehmensberatung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Geneva
- Art
- Selbständig
- Gegründet
- 2022
- Spezialgebiete
- consulting, pharma, biotech, medical device, CMC, drug development, Regulatory, quality assurance, analytical, bioanalytical, chemoinformatics, computational chemistry, GMP, GDP, life-cycle management, geographical expansion und CTD
Orte
-
Primär
Wegbeschreibung
Geneva, CH
-
Wegbeschreibung
Montreal, CA
Beschäftigte von MBS CONSULTING
Updates
-
✅ Stay up to date with the new EMA website
We are thrilled to announce that our new website is live! 🎉 We have re-designed it and improved its navigation to help you find the information you need more easily: https://lnkd.in/eue67S-w Get easier access to information on the medicines EMA evaluates thanks to: ✅ a new, simple search function by medicine name or active substance; ✅ a revamped What’s new page, that uses simple filters and sorting options. EMA is always open to suggestions for improvements to its website. Any proposals or issues with the website can be submitted via the email address given in the news announcement shared in comments. Take a minute to explore our new website. #NewWebsite #LaunchDay #ExploreWithUs #EMAWebsite #HealthCommunication
-
-
MBS Consulting attended a congress “A3P Procédés de Biothérapie”. Great speakers and insights 👍🧬💡!!! #cell&gene therapy#viral vectors #ARNm
C'est aujourd'hui que se tient l'événement A3P Procédés de Biothérapie à Lyon. Un grand merci à tous les participants, conférenciers et exposants qui contribuent à faire de cet événement un véritable succès, riche en échanges et en retours d’expérience. #a3p #evenement #pharma #biotherapie #jesuisbpf
-
-
✅ Stay up to date with the latest FDA Guidance document, Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs). The guidance gives both applicants and manufacturers of drugs recommendations for estimating the mutagenic and carcinogenic potential of NDSRIs that could be in drug products and gives acceptable intake (AI) limits for NDSRIs. ✓ The agency is also launching web content about NDSRIs on a dedicated webpage: https://lnkd.in/gyHFYGn5 #fda #nitrosamines #pharmaceuticalindustry #healthcare #impurities #drugs
-
✅ Stay up to date with the latest FDA Guidance for Benefit-Risk Assessment for New Drugs and Biologics.
FDA finalized a guidance intended to clarify for drug sponsors and other stakeholders how considerations about a drug’s benefits, risks, and risk management options factor into certain premarket and postmarket regulatory decisions: https://lnkd.in/dzaR3KiQ
-
A good definition of the role of a QA consultant and how we can support industry 👩💻 💊 #biotech#pharma#medicaldevice#QA#consultant#GMP#GDP#QMS#MDR#audit#inspection#QP#RP#CAPA https://lnkd.in/e6cUwUNw
-
🎉 We are pleased to announce the launch of MBS CONSULTING website 🎉 It will bring to light Who we are and How we work. Come and visit us 👉 https://mbs-consulting.ch #consulting#consultant#pharma#biotech#medicaldevice#CMC#drugdevelopment#regulatory#qualityassurance#analytical#bioanalytical#chemoinformatics#computationalchemistry#GMP#GDP#lifecyclemanagement#geographicalexpansion#CTD
Home - MBS Consulting
mbs-consulting.ch